Letter to Vertex: CF Community Demands Global Access to Trikafta

Cystic fibrosis patients, families, and advocates from over 60 countries write to Vertex Pharmaceuticals to demand access to the life-saving medication, Trikafta. They call for the company to drop patent claims, reduce prices, and facilitate access worldwide, emphasising the urgent need for action to alleviate the suffering of thousands of patients.

Read More
Allaa Aldaraji